Vida Ebrahimi

407 total citations
19 papers, 294 citations indexed

About

Vida Ebrahimi is a scholar working on Molecular Biology, Biotechnology and Ecology. According to data from OpenAlex, Vida Ebrahimi has authored 19 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Biotechnology and 3 papers in Ecology. Recurrent topics in Vida Ebrahimi's work include Microbial Community Ecology and Physiology (3 papers), CRISPR and Genetic Engineering (3 papers) and Air Quality and Health Impacts (2 papers). Vida Ebrahimi is often cited by papers focused on Microbial Community Ecology and Physiology (3 papers), CRISPR and Genetic Engineering (3 papers) and Air Quality and Health Impacts (2 papers). Vida Ebrahimi collaborates with scholars based in Iran, United States and United Kingdom. Vida Ebrahimi's co-authors include Vahideh Tarhriz, Shirin Eyvazi, Atieh Hashemi, Hadi Ebrahimi, Robab Azargun, Tahereh Ebrahimi, Marjan Talebi, Selen İlgün, Saeed Samarghandian and Tahereh Farkhondeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Biomedicine & Pharmacotherapy.

In The Last Decade

Vida Ebrahimi

16 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vida Ebrahimi Iran 8 142 34 32 32 30 19 294
Hui Dong China 10 249 1.8× 28 0.8× 33 1.0× 15 0.5× 37 1.2× 24 499
Yan Cui China 13 210 1.5× 21 0.6× 21 0.7× 11 0.3× 34 1.1× 25 410
Handan Tuncel Türkiye 11 128 0.9× 29 0.9× 24 0.8× 85 2.7× 49 1.6× 20 460
Yibo Tang China 10 123 0.9× 34 1.0× 30 0.9× 41 1.3× 23 0.8× 33 435
Loganathan Chandramani Priya Dharshini India 5 110 0.8× 29 0.9× 21 0.7× 23 0.7× 25 0.8× 10 267
Shanshan Su China 13 208 1.5× 30 0.9× 55 1.7× 54 1.7× 41 1.4× 39 493
Wenke Zhou China 11 127 0.9× 36 1.1× 30 0.9× 26 0.8× 22 0.7× 16 337
Rachel Matar United Arab Emirates 9 189 1.3× 12 0.4× 30 0.9× 22 0.7× 25 0.8× 17 380
Mateus Prates Mori Brazil 12 204 1.4× 41 1.2× 16 0.5× 18 0.6× 55 1.8× 25 450
Jingwei Xiao China 11 224 1.6× 23 0.7× 68 2.1× 78 2.4× 12 0.4× 35 430

Countries citing papers authored by Vida Ebrahimi

Since Specialization
Citations

This map shows the geographic impact of Vida Ebrahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vida Ebrahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vida Ebrahimi more than expected).

Fields of papers citing papers by Vida Ebrahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vida Ebrahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vida Ebrahimi. The network helps show where Vida Ebrahimi may publish in the future.

Co-authorship network of co-authors of Vida Ebrahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Vida Ebrahimi. A scholar is included among the top collaborators of Vida Ebrahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vida Ebrahimi. Vida Ebrahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ebrahimi, Vida, et al.. (2025). Exosomes in assisted reproductive technologies: Discovery of new mechanisms and therapeutic possibilities. Biomedicine & Pharmacotherapy. 193. 118889–118889.
2.
Ebrahimi, Vida & Atieh Hashemi. (2024). Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology. Folia Microbiologica. 69(6). 1205–1219. 1 indexed citations
3.
Ebrahimi, Vida & Atieh Hashemi. (2024). CRISPR-based gene editing in plants: Focus on reagents and their delivery tools. Bioimpacts. 15. 30019–30019. 2 indexed citations
4.
Ebrahimi, Vida, et al.. (2023). Exposure assessment to BTEX in the air of nail salons in Tehran city, Iran. Heliyon. 9(7). e18195–e18195. 7 indexed citations
5.
Ebrahimi, Vida, et al.. (2023). Assessing occupational exposure of airborne PMs and TVOCs in the nail salons in Tehran city, Iran. Heliyon. 9(12). e23088–e23088. 2 indexed citations
6.
Talebi, Marjan, et al.. (2022). A New Insight on Feasibility of Pre-, Pro-, and Synbiotics-based Therapies in Alzheimer’s Disease. Journal of Reports in Pharmaceutical Sciences. 11(2). 141–155. 7 indexed citations
7.
Ebrahimi, Vida & Atieh Hashemi. (2021). The Fabulous Impact of CRISPR Method in Sickle Cell Disease Treatment. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Ahangari, Hossein, Kamran Hosseini, Vida Ebrahimi, et al.. (2021). Colorectal cancer treatment using bacteria: focus on molecular mechanisms. BMC Microbiology. 21(1). 218–218. 27 indexed citations
10.
Ahangari, Hossein, Vida Ebrahimi, Saiedeh Razi Soofiyani, et al.. (2021). An Updated review on production of food derived bioactive peptides; focus on the psychrotrophic bacterial proteases. Biocatalysis and Agricultural Biotechnology. 35. 102051–102051. 14 indexed citations
11.
Ahangari, Hossein, Haleh Forouhandeh, Tahereh Ebrahimi, et al.. (2021). Pseudomonas sp. a Dominant Population of Bacteria in the Cold Water of Mount Sabalan Crater Lake. Current Biotechnology. 10(3). 210–217.
12.
Ebrahimi, Vida & Atieh Hashemi. (2020). Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review. Gene. 753. 144813–144813. 24 indexed citations
13.
Ebrahimi, Vida, et al.. (2020). Epigenetic modifications in gastric cancer: Focus on DNA methylation. Gene. 742. 144577–144577. 69 indexed citations
14.
Talebi, Marjan, Selen İlgün, Vida Ebrahimi, et al.. (2020). Zingiber officinale ameliorates Alzheimer’s disease and Cognitive Impairments: Lessons from preclinical studies. Biomedicine & Pharmacotherapy. 133. 111088–111088. 55 indexed citations
15.
Ebrahimi, Vida, Shirin Eyvazi, Soheila Montazersaheb, et al.. (2020). Polycyclic Aromatic Hydrocarbons Degradation by Aquatic Bacteria Isolated from Khazar Sea, the World’s Largest Lake. Pharmaceutical Sciences. 27(1). 121–130. 6 indexed citations
16.
Yousefi, Vahid, Vida Ebrahimi, Shirin Eyvazi, et al.. (2020). Overview of ultraviolet‐based methods used in polycyclic aromatic hydrocarbons analysis and measurement. Separation Science Plus. 3(4). 112–120. 17 indexed citations
17.
Tarhriz, Vahideh, Imen Nouioui, Cathrin Spröer, et al.. (2019). Pseudomonas khazarica sp. nov., a polycyclic aromatic hydrocarbon-degrading bacterium isolated from Khazar Sea sediments. Antonie van Leeuwenhoek. 113(4). 521–532. 19 indexed citations
18.
Farajdokht, Fereshteh, et al.. (2018). Garlic (Allium sativum) improves anxiety- and depressive-related behaviors and brain oxidative stress in diabetic rats. Archives of Physiology and Biochemistry. 126(2). 95–100. 39 indexed citations
19.
Ebrahimi, Vida, et al.. (2017). 133: THE EFFECT OF ZINGIBER OFFICINALE (GINGER) ON HYPERTENSION; A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS. BMJ Open. 7(Suppl 1). bmjopen–2016. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026